Net profit of Healthcare Global Enterprises rose 32.57% to Rs 17.99 crore in the quarter ended September 2024 as against Rs 13.57 crore during the previous quarter ended September 2023. Sales rose 13.69% to Rs 552.47 crore in the quarter ended September 2024 as against Rs 485.96 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales552.47485.96 14 OPM %18.5117.41 - PBDT77.3961.13 27 PBT27.6517.92 54 NP17.9913.57 33 Powered by Capital Market - Live News

Healthcare Global Enterprises has executed Business Transfer Agreement on 09 November 2024 (BTA), with HCG NCHRI Oncology LLP, a wholly owned subsidiary, for the acquisition of the oncology business of HCG NCHRI Oncology LLP, located at Nagpur, on a slump sale basis. The consideration payable to the Company by the Seller shall not exceed Rs 25 crore, which shall be determined on the effective date of transfer.Powered by Capital Market - Live News

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company on 9 November 2024.Powered by Capital Market - Live News

Healthcare Global Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live News

Net profit of Healthcare Global Enterprises rose 58.74% to Rs 12.08 crore in the quarter ended June 2024 as against Rs 7.61 crore during the previous quarter ended June 2023. Sales rose 14.14% to Rs 524.69 crore in the quarter ended June 2024 as against Rs 459.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales524.69459.71 14 OPM %17.3216.16 - PBDT66.0051.53 28 PBT18.9910.52 81 NP12.087.61 59 Powered by Capital Market - Live News